drugset / Trial / NCT00167791
Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a study of patients who have a high risk of kidney rejection before kidney transplant. The hypothesis is that treatment with a medication called rituximab will make it possible for them to receive a kidney transplant from a donor who previously did not present a good match.
Timeline
- Start
- 2005-07
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rituximab | Monoclonal antibody | 375 mg/m2 | Intravenous |